Search by Drug Name or NDC

    NDC 68001-0438-96 Loratadine 10 mg/1 Details

    Loratadine 10 mg/1

    Loratadine is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by BluePoint Laboratories. The primary component is LORATADINE.

    Product Information

    NDC 68001-0438
    Product ID 68001-438_e1e021de-1501-2fe3-e053-2a95a90a7be9
    Associated GPIs 41550030000320
    GCN Sequence Number 018698
    GCN Sequence Number Description loratadine TABLET 10 MG ORAL
    HIC3 Z2Q
    HIC3 Description ANTIHISTAMINES - 2ND GENERATION
    GCN 60563
    HICL Sequence Number 007605
    HICL Sequence Number Description LORATADINE
    Brand/Generic Generic
    Proprietary Name Loratadine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Loratadine
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name LORATADINE
    Labeler Name BluePoint Laboratories
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208314
    Listing Certified Through 2024-12-31

    Package

    NDC 68001-0438-96 (68001043896)

    NDC Package Code 68001-438-96
    Billing NDC 68001043896
    Package 10 BLISTER PACK in 1 CARTON (68001-438-96) / 10 TABLET in 1 BLISTER PACK (68001-438-16)
    Marketing Start Date 2020-08-26
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.05481
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description LORATADINE 10 MG TABLET
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL adc506ed-7a7a-facc-e053-2a95a90ae147 Details

    Revised: 6/2022